Yi Cunjian, Li Li, Chen Keming, Lin Shengrong, Liu Xiangqiong
Department of Obstetrics and Gynecology, First Affiliated Hospital, Yangtze University, Jingzhou, Hubei 434000, P.R. China.
Oncol Lett. 2012 Feb;3(2):369-372. doi: 10.3892/ol.2011.481. Epub 2011 Nov 15.
The purpose of this study was to investigate the expression of c-Kit and platelet-derived growth factor receptor α (PDGFRα) in epithelial ovarian tumor cells and tumor stroma. The expression of c-Kit and PDGFRα in 71 malignant or benign epithelial ovarian tumor tissues and 20 normal ovarian tissues was evaluated by immunohistochemical staining. The expression of c-Kit and PDGFRα in 71 malignant epithelial ovarian tumors and tumor stroma tissue samples was analyzed. A significant increase (P<0.01) of c-Kit expression was observed in malignant ovarian tumors (50.7%) when compared to normal ovarian tissues (10.0%) or benign ovarian tumors (20.0%). The PDGFRα expression rate in malignant ovarian tumors (63.4%) was also significantly higher (P<0.01) than that in normal ovarian tissues (15.0%) or benign ovarian tumors (25.0%). c-Kit was expressed in only 4.2% of the tumor stroma samples, which was significantly lower than the expression of malignant ovarian tumors (P<0.01), whereas the PDGFRα expression in tumor stroma (87.3%) was significantly higher than that of the malignant ovarian tumors (P<0.01). The expression levels of c-Kit and PDGFRα are higher in the malignant ovarian tumors than in the benign ovarian tumors or normal tissues. In the malignant ovarian tumor stroma, c-Kit expression is low and PDGFRα expression is high, and the differential changes of c-kit and PDGFRα suggest distinct roles in ovarian cancer.
本研究的目的是调查c-Kit和血小板衍生生长因子受体α(PDGFRα)在上皮性卵巢肿瘤细胞和肿瘤基质中的表达情况。采用免疫组织化学染色法评估71例恶性或良性上皮性卵巢肿瘤组织及20例正常卵巢组织中c-Kit和PDGFRα的表达。分析71例恶性上皮性卵巢肿瘤及肿瘤基质组织样本中c-Kit和PDGFRα的表达。与正常卵巢组织(10.0%)或良性卵巢肿瘤(20.0%)相比,恶性卵巢肿瘤中c-Kit表达显著增加(P<0.01)(50.7%)。恶性卵巢肿瘤中PDGFRα表达率(63.4%)也显著高于正常卵巢组织(15.0%)或良性卵巢肿瘤(25.0%)(P<0.01)。c-Kit仅在4.2%的肿瘤基质样本中表达,显著低于恶性卵巢肿瘤的表达(P<0.01),而肿瘤基质中PDGFRα表达(87.3%)显著高于恶性卵巢肿瘤(P<0.01)。恶性卵巢肿瘤中c-Kit和PDGFRα的表达水平高于良性卵巢肿瘤或正常组织。在恶性卵巢肿瘤基质中,c-Kit表达低而PDGFRα表达高,c-kit和PDGFRα的差异变化提示它们在卵巢癌中发挥不同作用。